 |
September 27, 2005 BioVitesse to present at Chicago venture forum showcasing women-led firmsWEST LAFAYETTE, Ind. - Springboard: Midwest today announced that it has selected BioVitesse Inc., a Purdue Research Park biotechnology company led by Laila Razouk, to present at the Springboard 2005: Midwest Venture Forum on Wednesday (Sept. 28) at Northwestern University's Thorne Auditorium. The forum, which showcases the region's most talented women entrepreneurs to an audience of the Midwest's top corporate, angel and venture investors, is hosted by Northwestern University's Center for Women Entrepreneurs in Technology (CWET) and Springboard Enterprises. Featured presenters include biotechnology, life sciences, medical devices, software, technology, business services and consumer-products companies. "Enabled by a proprietary micro-fluidic biochip technology that BioVitesse has licensed from Purdue University, our quality control monitoring systems detect and identify live bacteria in two to four hours rather than the traditional two to seven days - a breakthrough in the fast-growing industrial microbiological control market," said Laila R. Razouk, BioVitesse's president and CEO. "We are excited with the market opportunity ahead of us and with the excellent feedback we're getting from our potential customers." Prior to participating in the forum, presenting companies underwent a three-month selection, training and coaching program that involved hundreds of investors, accountants, lawyers, bankers and business development professionals. "Springboard Venture Forum will proactively connect these hardworking women-led companies with regional investment capital opportunities," said CWET Director Nancy Sullivan. Event Speaker: Laila R. Razouk, Ph.D. When: Wednesday, Sept. 28, 2005 Where: Northwestern University's Thorne Auditorium About BioVitesse Founded in 2002, BioVitesse Inc. is a privately held biotechnology company with offices in San Jose, Calif., and the Purdue Research Park in West Lafayette, Ind., that develops, manufactures and markets automated in-process quality control monitoring systems and solutions for rapid bacterial detection and identification for the industrial microbiological markets. The company's mission is to become the global market leader with an initial focus on the bio/pharmaceutical segment followed by the food safety and the drinking water safety segments. BioVitesse is funded by National Science Foundation SBIR Phase I and Phase II grants, the Indiana 21st Century Research and Technology Fund, angel investors and the company's founders. Contact: Laila R. Razouk, (408) 930-4044, laila.razouk@biovitesse.com |
